A new method for investigating microbiota-produced small molecules in adenomatous polyps

Area of Science:

• Microbiology
• Metabolomics
• Oncology

Background:

• The intestinal microbiota significantly influences colorectal cancer (CRC) development, which often arises from adenomatous polyps.
• Studying microbiota-produced metabolites is crucial for understanding molecular changes during the benign-to-malignant transformation of polyps.
• Existing methods face challenges in capturing the full metabolic complexity of the microbiota.

Purpose of the Study:

• To develop a novel high-throughput metabolomics method for analyzing the microbiota metabolome associated with colorectal adenomas and adenocarcinomas.
• To enable simultaneous quantification of a large number of metabolites while maintaining sample integrity.

Main Methods:

• Development of a high-throughput metabolomics technique.
• Analytical validation of the method, assessing recovery, linearity, specificity, precision, and detection/quantification limits.
• Application of the method to adenoma samples from a colorectal adenoma study.

Main Results:

• The developed method allows for the simultaneous quantification of nearly 300 metabolites.
• The method demonstrated excellent analytical performance, meeting rigorous validation criteria.
• The clinical potential was successfully demonstrated using samples from a colorectal adenoma study.

Conclusions:

• The novel high-throughput metabolomics method effectively captures the metabolic complexity of the microbiota in colorectal polyps and cancer.
• This approach provides a powerful tool for discovering new insights into colorectal cancer development and progression.
• The validated method shows significant clinical potential for future research and diagnostics.